MedPacto (Korea) Analysis
| 235980 Stock | KRW 4,650 50.00 1.06% |
MedPacto is overvalued with Real Value of 4371.0 and Hype Value of 4700.0. The main objective of MedPacto stock analysis is to determine its intrinsic value, which is an estimate of what MedPacto is worth, separate from its market price. There are two main types of MedPacto's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect MedPacto's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of MedPacto's stock to identify patterns and trends that may indicate its future price movements.
The MedPacto stock is traded in Korea on KOSDAQ, with the market opening at 09:00:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MedPacto's ongoing operational relationships across important fundamental and technical indicators.
MedPacto |
MedPacto Stock Analysis Notes
About 34.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. MedPacto had 2:1 split on the 13th of May 2020. MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers MS-1601A that targets TRG1 for cancers and autoimmune diseases and vactosertib for solid tumors. MedPacto is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on MedPacto please contact the company at 82 2 6938 0200 or go to http://www.medpacto.com.MedPacto Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. MedPacto's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding MedPacto or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| MedPacto generated a negative expected return over the last 90 days | |
| MedPacto has high historical volatility and very poor performance | |
| Net Loss for the year was (17.04 B) with loss before overhead, payroll, taxes, and interest of (1.66 M). | |
| MedPacto has accumulated about 1.29 B in cash with (25.15 B) of positive cash flow from operations. | |
| Roughly 34.0% of the company shares are owned by insiders or employees |
MedPacto Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 440.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MedPacto's market, we take the total number of its shares issued and multiply it by MedPacto's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 19th of December, MedPacto secures the Risk Adjusted Performance of (0.07), mean deviation of 2.48, and Standard Deviation of 3.48. MedPacto technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.MedPacto Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. MedPacto middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for MedPacto. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
MedPacto Predictive Daily Indicators
MedPacto intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MedPacto stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 5267.1 | |||
| Daily Balance Of Power | (0.27) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 4637.5 | |||
| Day Typical Price | 4641.67 | |||
| Market Facilitation Index | 0.0014 | |||
| Price Action Indicator | (12.50) | |||
| Period Momentum Indicator | (50.00) |
MedPacto Forecast Models
MedPacto's time-series forecasting models are one of many MedPacto's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MedPacto's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About MedPacto Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how MedPacto prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MedPacto shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MedPacto. By using and applying MedPacto Stock analysis, traders can create a robust methodology for identifying MedPacto entry and exit points for their positions.
MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers MS-1601A that targets TRG1 for cancers and autoimmune diseases and vactosertib for solid tumors. MedPacto is traded on Korean Securities Dealers Automated Quotations in South Korea.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding MedPacto to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Complementary Tools for MedPacto Stock analysis
When running MedPacto's price analysis, check to measure MedPacto's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedPacto is operating at the current time. Most of MedPacto's value examination focuses on studying past and present price action to predict the probability of MedPacto's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedPacto's price. Additionally, you may evaluate how the addition of MedPacto to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets |